Small bowel capsule endoscopy (SBCE) is the gold standard for suspected small bowel bleeding (SBB). Angioectasias are the most common vascular anomalies in the gastrointestinal tract and have been reported as the source of SBB in up to 80% of patients. Considering their frequency, their usual intermittent bleeding nature, and their risk of rebleeding, the aim of this study was to identify some features and possible predictors of rebleeding in the presence of these lesions.
This is a retrospective study, which included consecutive SBCE with angioectasias between April 2008 and December 2017 with a minimum follow-up of 12 months. Rebleeding was defined as a drop of hemoglobin ≥ 2 g/dl and/or in the presence of hematochezia or melenas with negative esophagogastroduodenoscopy and ileocolonoscopy. Data were collected from medical records, and angioectasias were classified by number, location, size, and type. Univariate and multivariable statistical analysis was performed to identify possible predictors of rebleeding.
From a total of 630 patients submitted to SBCE for suspected SBB, 129 with angioectasias were included; 59.7% were female, with a median age of 72 (19–91) years old and a mean follow-up of 44.0 ± 31.9 months. In 32.6% (n = 42) of the patients, at least one episode of rebleeding was documented. The presence of heart failure (OR 3.41; IC95% 1.18–9.89; p = 0.024), the size of the angioectasias (OR 5.41; IC95% 2.15–13.6; p < 0.001), and smoking status (OR 3.15; IC95% 1.07–9.27; p = 0.038) were independent predictor factors of rebleeding.
Heart failure, smoking status, and angioectasias with a size superior to 5 mm are independent predictor factors of rebleeding in a population with angioectasias diagnosed by SBCE.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Gerson LB, Fidler JL, Cave DR, Leighton JA. ACG clinical guideline: diagnosis and management of small bowel bleeding. Am J Gastroenterol. 2015;110:1265–1287. (quiz 88).
Rondonotti E, Spada C, Adler S, et al. Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) technical review. Endoscopy. 2018;50:423–446.
Gunjan D, Sharma V, Rana SS, Bhasin DK. Small bowel bleeding: a comprehensive review. Gastroenterol Rep. 2014;2:262–275.
Rosa B, Cotter J. Current clinical indications for small bowel capsule endoscopy. Acta Med Port. 2015;28:632–639.
Dionisio PM, Gurudu SR, Leighton JA, et al. Capsule endoscopy has a significantly higher diagnostic yield in patients with suspected and established small-bowel Crohn’s disease: a meta-analysis. Am J Gastroenterol. 2010;105:1240–1248. quiz 9.
Zhang QHQ, Liu J, Ma F, Zhi F, Bai Y. Combined use of capsule endoscopy and double-balloon enteroscopy in the diagnosis of obscure gastrointestinal bleeding: meta-analysis and pooled analysis. Hepato-gastroenterology. 2013;60:1885–1891.
Liao Z, Gao R, Xu C, Li ZS. Indications and detection, completion, and retention rates of small-bowel capsule endoscopy: a systematic review. Gastrointest Endosc. 2010;71:280–286.
Chetcuti Zammit S, Koulaouzidis A, Sanders DS, et al. Overview of small bowel angioectasias: clinical presentation and treatment options. Expert Rev Gastroenterol Hepatol. 2018;12:125–139.
Ponte A, Perez-Cuadrado Robles E, Pinho R, et al. High short-term rebleeding rate in patients undergoing a second endoscopic therapy for small-bowel angioectasias after recurrent bleeding. Rev esp enfermedades dig organo of Soc Esp Patol Dig. 2018;110:88–93.
Yano T, Yamamoto H, Sunada K, et al. Endoscopic classification of vascular lesions of the small intestine (with videos). Gastrointest Endosc. 2008;67:169–172.
Cúrdia Gonçalves TMJ, Boal Carvalho P, Moreira MJ, Rosa B, Cotter J. Is it possible to predict the presence of intestinal angioectasias? Diagn Ther Endosc. 2014;2014:461602.
Nennstiel S, Machanek A, von Delius S, et al. Predictors and characteristics of angioectasias in patients with obscure gastrointestinal bleeding identified by video capsule endoscopy. United Eur Gastroenterol J. 2017;5:1129–1135.
Igawa A, Oka S, Tanaka S, et al. Major predictors and management of small-bowel angioectasia. BMC Gastroenterol. 2015;15:108.
Yamada A, Niikura R, Kobayashi Y, et al. Risk factors for small bowel angioectasia: the impact of visceral fat accumulation. World J Gastroenterol. 2015;21:7242–7247.
Zajjari YTM, Montasser D, Hassani K, Aatif T, El Kabbaj D, Benyahia M. Gastrointestinal bleeding due to angioectasia in patients on hemodialysis: a single center study. Saudi J Kidney Dis Transpl. 2016;27:748–751.
Romagnuolo J, Brock AS, Ranney N. Is endoscopic therapy effective for angioectasia in obscure gastrointestinal bleeding? A systematic review of literature. J Clin Gastroenterol. 2015;49:823–830.
Pinho R, Ponte A, Rodrigues A, et al. Long-term rebleeding risk following endoscopic therapy of small-bowel vascular lesions with device-assisted enteroscopy. Eur J Gastroenterol Hepatol. 2016;28:479–485.
Curdia Goncalves T, Arieira C, Monteiro S, Rosa B, Moreira MJ, Cotter J. ORBIT score: an useful predictor of small bowel rebleeding in patients under chronic anticoagulation. Scand J Gastroenterol. 2018;53:179–184.
Curdia Goncalves T, Dias de Castro F, Moreira MJ, Rosa B, Cotter J. Small bowel capsule endoscopy in obscure gastrointestinal bleeding: normalcy is not reassuring. Eur J Gastroenterol Hepatol. 2014;26:927–932.
Niikura R, Yamada A, Nagata N, et al. New predictive model of rebleeding during follow-up of patents with obscure gastrointestinal bleeding: a multicenter cohort study. J Gastroenterol Hepatol. 2016;31:752–760.
Kaufman D, Leslie G, Marya N, et al. Small intestinal angioectasia: characterization, risk factors, and rebleeding. J Clin Gastroenterol. 2017;51:720–727.
Sakai E, Endo H, Taguri M, et al. Frequency and risk factors for rebleeding events in patients with small bowel angioectasia. BMC Gastroenterol. 2014;14:200.
Redondo-Cerezo E, Gomez-Ruiz CJ, Sanchez-Manjavacas N, et al. Long-term follow-up of patients with small-bowel angiodysplasia on capsule endoscopy. Determinants of a higher clinical impact and rebleeding rate. Rev esp enfermedades dig organo of Soc Esp Patol Dig. 2008;100:202–207.
Diggs NGHJ, Lieberman DA, Eisen GM, Strate L. Factors that contribute to blood loss in patients with colonic angiodysplasia from a population-based study. Clin Gastroenterol Hepatol. 2011;9:415–420.
Xavier S, Magalhaes J, Rosa B, Moreira MJ, Cotter J. Impact of small bowel capsule endoscopy in iron deficiency anemia: influence of patient’s age on diagnostic yield. Arq Gastroenterol. 2018;55:242–246.
Boal Carvalho P, Rosa B, Moreira MJ, Cotter J. New evidence on the impact of antithrombotics in patients submitted to small bowel capsule endoscopy for the evaluation of obscure gastrointestinal bleeding. Gastroenterol Res Pract. 2014;2014:709217.
Cho KM, Park SY, Chung JO, et al. Risk factors for small bowel bleeding in chronic nonsteroidal anti-inflammatory drug users. J Dig Dis. 2015;16:499–504.
Ormeci AAF, Baran B, Gokturk S, et al. What is the impact of capsule endoscopy in the long term period? World J Gastrointest Endosc. 2016;8:344–348.
Sidhu R, Sanders DS, Kapur K, Leeds JS, McAlindon ME. Factors predicting the diagnostic yield and intervention in obscure gastrointestinal bleeding investigated using capsule endoscopy. J Gastrointest Liver Dis JGLD. 2009;18:273–278.
Van Weyenberg SJ, Van Turenhout ST, Jacobs MA, Bouma G, Mulder CJ. Video capsule endoscopy for previous overt obscure gastrointestinal bleeding in patients using anti-thrombotic drugs. Dig Endosc Off J Jpn Gastroenterol Endosc Soc. 2012;24:247–254.
Han S, Leslie G, Kaufman D, et al. Su1225 smoking as a potential risk factor for the development of angioectasias. Gastrointest Endosc. 2016;83:A318–A319.
Heer M, Sulser H, Hany A. Angiodysplasia of the colon: an expression of occlusive vascular disease. Hepato-gastroenterology. 1987;34:127–131.
Iribarren C, Phelps BH, Darbinian JA, et al. Circulating angiopoietins-1 and -2, angiopoietin receptor Tie-2 and vascular endothelial growth factor-A as biomarkers of acute myocardial infarction: a prospective nested case-control study. BMC Cardiovasc Disord. 2011;11:31.
Bauditz J, Lochs H. Angiogenesis and vascular malformations: antiangiogenic drugs for treatment of gastrointestinal bleeding. World J Gastroenterol. 2007;13:5979–5984.
Holleran G, Hall B, Hussey M, McNamara D. Small bowel angiodysplasia and novel disease associations: a cohort study. Scand J Gastroenterol. 2013;48:433–438.
Chetcuti Zammit S, Sanders DS, Sidhu R. Lanreotide in the management of small bowel angioectasias: seven-year data from a tertiary centre. Scand J Gastroenterol. 2017;52:962–968.
Nardone G, Compare D, Martino A, Rocco A. Pharmacological treatment of gastrointestinal bleeding due to angiodysplasias: a position paper of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver. 2018;50:542–548.
Conflict of interest
Bruno Rosa has consulting services agreement with Medtronic®. Other authors have no conflict of interest to declare.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Arieira, C., Magalhães, R., Dias de Castro, F. et al. Small Bowel Angioectasias Rebleeding and the Identification of Higher Risk Patients. Dig Dis Sci 66, 175–180 (2021). https://doi.org/10.1007/s10620-020-06137-1
- Capsule endoscopy